Power D A, Burton J P, Chilcott C N, Dawes P J, Tagg J R
Department of Microbiology and Immunology, University of Otago, P.O. Box 56, Dunedin, New Zealand.
Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1261-3. doi: 10.1007/s10096-008-0569-4. Epub 2008 Jun 17.
A powder preparation of the oral probiotic Streptococcus salivarius K12 has been given to 19 young otitis media-prone children following a 3-day course of amoxicillin administered as a preliminary to ventilation tube placement. In two subjects, the use of strain K12 appeared to effect the expansion of an indigenous population of inhibitory S. salivarius. In other children, strain K12 colonisation extended beyond the oral cavity to also include the nasopharynx or adenoid tissue. The relatively low proportion (33%) of subjects that colonised was attributed to failure of the amoxicillin pre-treatment to sufficiently reduce the indigenous S. salivarius populations prior to dosing with strain K12 powder.
在19名易患中耳炎的儿童中,在作为置管术前预处理给予3天阿莫西林疗程后,给予口服益生菌唾液链球菌K12的粉剂制剂。在两名受试者中,使用菌株K12似乎影响了抑制性唾液链球菌本土菌群的扩增。在其他儿童中,菌株K12的定殖范围超出口腔,还包括鼻咽或腺样体组织。定殖的受试者比例相对较低(33%),这归因于阿莫西林预处理未能在给予菌株K12粉剂之前充分减少本土唾液链球菌菌群。